Immatics N.V.
IMTX
|
$10.19
-0.68%
-0.69%
180K
|
Health Technology
(0.0% 1d) (-10.0% 1m) (37.2% 1y) (0.0% 2d) (-0.2% 3d) (-1.8% 7d) (-62.42% volume)
Earnings Calendar: 2024-03-19
Market Cap: $ 1,049,417,884
http://www.immatics.com
Sec Filling | Patents | 227 employees
(DE) Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCER™). Its therapeutic approaches are ACTengine, Next Generation ACT, and TCER. The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany.
cancer immunotherapy t-cell treatment ceiling
add to watch list Paper trade email alert is off
Press-releases
Immatics Announces Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: -12.45%
H: 16.68%
C: 7.49%
year update financial results
Immatics Announces Pricing of $175 Million Public Offering
Published: 2024-01-18 (Crawled : 02:00) - globenewswire.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 3.57%
H: 0.6%
C: -2.24%
million offering
Immatics Announces Proposed Public Offering
Published: 2024-01-17 (Crawled : 21:00) - globenewswire.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 3.57%
H: 0.6%
C: -2.24%
offering
DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing
Published: 2024-01-16 (Crawled : 09:00) - prnewswire.com
COYA | $7.87 -6.75% -7.24% 54K
|
|
| O: -2.73%
H: 2.64%
C: -7.76%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: -0.83%
H: 0.12%
C: -4.76%
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: -1.67%
H: 0.08%
C: -2.03%
company million pharmaceuticals
Levicept Appoints Eliot Forster as CEO
Published: 2023-11-30 (Crawled : 11:00) - biospace.com/
IMCR | $55.71 1.77% 1.74% 450K
|
Manufacturing
|
| O: 0.14%
H: 7.22%
C: 6.68%
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 1.63%
H: 1.83%
C: 1.14%
PLX | $1.15 1.77% -2.61% 450K
|
Health Services
|
| O: 0.0%
H: 6.29%
C: 5.59%
ceo
Immatics Announces Third Quarter 2023 Financial Results and Business Update
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 0.42%
H: 6.25%
C: 1.04%
business update financial results
Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
Published: 2023-11-08 (Crawled : 12:00) - globenewswire.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 1.11%
H: 2.09%
C: -4.97%
ima203 actengine ongoing trial
Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
Published: 2023-10-24 (Crawled : 11:00) - globenewswire.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: -0.13%
H: 4.18%
C: 1.77%
ima203 actengine fda designation therapy
Moderna – Research & Development Collaboration
Published: 2023-09-11 (Crawled : 15:00) - immatics.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 6.73%
H: 1.08%
C: -4.31%
research collaboration
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
Published: 2023-09-11 (Crawled : 11:00) - globenewswire.com
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.78%
H: 0.42%
C: -0.94%
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 6.73%
H: 1.08%
C: -4.31%
collaboration therapeutics
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10